Payment overview · 2025
General Payments
$574.96
12 reported records · 3 companies
Healthcare provider profile · identity verified
James D Pike, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · INDIANAPOLIS, IN · NPI 1366443400
Verified facts
What the public records show
CMS Open Payments records show James D Pike, D.O. received $574.96 in general payments during 2025 across 12 reported records.
AstraZeneca Pharmaceuticals LP accounted for 46.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Farxiga by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 39 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 241 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $266.18 | 46.3% | 3 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $255.98 | 44.5% | 6 | 2025 |
| Ferring Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $52.80 | 9.2% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $574.96 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUCALA Normalized: nucala |
Biological | GlaxoSmithKline, LLC. | $129.15 | 4 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $121.18 | 1 | 2025 |
Source payment records
|
|||||
| FASENRA Normalized: fasenra |
Biological | AstraZeneca Pharmaceuticals LP | $121.18 | 1 | 2025 |
Source payment records
|
|||||
| TEZSPIRE Normalized: tezspire |
Biological | AstraZeneca Pharmaceuticals LP | $116.10 | 1 | 2025 |
Source payment records
|
|||||
| ADSTILADRIN Normalized: adstiladrin |
Biological | Ferring Pharmaceuticals Inc. | $52.80 | 3 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $28.90 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $5.65 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 241 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
36 | suppressed by CMS |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
39 | 26 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
241 | 42 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2381 | 402 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1491 | 228 |
| Sertraline Hcl | Sertraline Hcl | 1379 | 223 |
| Amlodipine Besylate | Amlodipine Besylate | 1312 | 236 |
| Gabapentin | Gabapentin | 1262 | 211 |
| Eliquis | Apixaban | 1225 | 173 |
| Pantoprazole Sodium | Pantoprazole Sodium | 897 | 166 |
| Potassium Chloride | Potassium Chloride | 854 | 174 |
| Metoprolol Succinate | Metoprolol Succinate | 850 | 165 |
| Omeprazole | Omeprazole | 839 | 169 |
| Donepezil Hcl | Donepezil Hcl | 796 | 131 |
| Trazodone Hcl | Trazodone Hcl | 749 | 180 |
| Metoprolol Tartrate | Metoprolol Tartrate | 744 | 122 |
| Lisinopril | Lisinopril | 725 | 128 |
| Torsemide | Torsemide | 702 | 148 |
| Memantine Hcl | Memantine Hcl | 697 | 124 |
| Furosemide | Furosemide | 654 | 130 |
| Tamsulosin Hcl | Tamsulosin Hcl | 646 | 126 |
| Divalproex Sodium | Divalproex Sodium | 555 | 105 |
| Metformin Hcl | Metformin Hcl | 553 | 109 |
| Losartan Potassium | Losartan Potassium | 542 | 128 |
| Clopidogrel | Clopidogrel Bisulfate | 508 | 87 |
| Buspirone Hcl | Buspirone Hcl | 489 | 88 |
| Duloxetine Hcl | Duloxetine Hcl | 485 | 89 |
| Levetiracetam | Levetiracetam | 432 | 74 |
| Carvedilol | Carvedilol | 416 | 101 |
| Baclofen | Baclofen | 373 | 70 |
| Mirtazapine | Mirtazapine | 368 | 99 |
| Olanzapine | Olanzapine | 365 | 81 |
| Risperidone | Risperidone | 332 | 58 |
| Prednisone | Prednisone | 313 | 119 |
| Escitalopram Oxalate | Escitalopram Oxalate | 312 | 71 |
| Spironolactone | Spironolactone | 312 | 60 |
| Xarelto | Rivaroxaban | 298 | 34 |
| Allopurinol | Allopurinol | 281 | 43 |
| Famotidine | Famotidine | 270 | 41 |
| Jardiance | Empagliflozin | 265 | 38 |
| Doxycycline Hyclate | Doxycycline Hyclate | 250 | 115 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 241 | 42 |
| Cephalexin | Cephalexin | 229 | 105 |
| Ropinirole Hcl | Ropinirole Hcl | 220 | 32 |
| Latanoprost | Latanoprost | 219 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 203 | 72 |
| Quetiapine Fumarate | Quetiapine Fumarate | 191 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 189 | 93 |
| Hydralazine Hcl | Hydralazine Hcl | 185 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 183 | 39 |
| Alendronate Sodium | Alendronate Sodium | 176 | 31 |
| Sodium Chloride | 0.9 % Sodium Chloride | 165 | 68 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 164 | 22 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 163 | 87 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 159 | 50 |
| Finasteride | Finasteride | 159 | 33 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 159 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 156 | 31 |
| Myrbetriq | Mirabegron | 156 | 19 |
| Montelukast Sodium | Montelukast Sodium | 152 | 35 |
| Ondansetron Odt | Ondansetron | 152 | 67 |
| Tradjenta | Linagliptin | 152 | 26 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 149 | 82 |
| Simvastatin | Simvastatin | 145 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 143 | 56 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 138 | 50 |
| Breo Ellipta | Fluticasone/Vilanterol | 134 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 134 | 25 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 131 | 62 |
| Loperamide | Loperamide Hcl | 127 | 69 |
| Clozapine | Clozapine | 125 | 12 |
| Trulicity | Dulaglutide | 123 | 25 |
| Clonazepam | Clonazepam | 121 | 19 |
| Amiodarone Hcl | Amiodarone Hcl | 120 | 27 |
| Lamotrigine | Lamotrigine | 114 | 18 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 113 | 27 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 111 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 110 | 24 |
| Warfarin Sodium | Warfarin Sodium | 110 | 15 |
| Nystatin | Nystatin | 109 | 50 |
| Tramadol Hcl | Tramadol Hcl | 109 | 20 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 108 | 16 |
| Fluconazole | Fluconazole | 108 | 60 |
| Lactulose | Lactulose | 108 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 107 | 66 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 107 | 66 |
| Ezetimibe | Ezetimibe | 106 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 105 | 70 |
| Midodrine Hcl | Midodrine Hcl | 104 | 48 |
| Atenolol | Atenolol | 102 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 102 | 21 |
| Ceftriaxone | Ceftriaxone Sodium | 98 | 60 |
| Clonidine Hcl | Clonidine Hcl | 96 | 32 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 96 | 47 |
| Bupropion Xl | Bupropion Hcl | 91 | 19 |
| Januvia | Sitagliptin Phosphate | 91 | 14 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 85 | 19 |
| Nifedipine Er | Nifedipine | 84 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 83 | 21 |
| Glipizide | Glipizide | 82 | 16 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 79 | 35 |
| Insulin Lispro | Insulin Lispro | 78 | 41 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 77 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 74 | 37 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 73 | 15 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 73 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 73 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 73 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 71 | 31 |
| Hydrocortisone | Hydrocortisone | 69 | 27 |
| Propranolol Hcl | Propranolol Hcl | 69 | 13 |
| Divalproex Sodium Er | Divalproex Sodium | 68 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 66 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 65 | 26 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 64 | 17 |
| Incruse Ellipta | Umeclidinium Bromide | 63 | 15 |
| Rivastigmine | Rivastigmine | 63 | 17 |
| Fenofibrate | Fenofibrate Nanocrystallized | 62 | 12 |
| Pregabalin | Pregabalin | 61 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 60 | 37 |
| Brimonidine Tartrate | Brimonidine Tartrate | 59 | 14 |
| Lidocaine Hcl | Lidocaine Hcl | 58 | 37 |
| Gemtesa | Vibegron | 57 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 24 |
| Entresto | Sacubitril/Valsartan | 55 | 13 |
| Lorazepam | Lorazepam | 55 | 16 |
| Meloxicam | Meloxicam | 55 | 15 |
| Methenamine Hippurate | Methenamine Hippurate | 54 | suppressed |
| Paliperidone Er | Paliperidone | 54 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 53 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 53 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 52 | 22 |
| Aptiom | Eslicarbazepine Acetate | 51 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 51 | suppressed |
| Lidocaine | Lidocaine | 50 | suppressed |
| Metolazone | Metolazone | 50 | suppressed |
| Sucralfate | Sucralfate | 49 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | 25 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 49 | 19 |
| Digoxin | Digoxin | 48 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 48 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 48 | 15 |
| Venlafaxine Hcl | Venlafaxine Hcl | 48 | suppressed |
| Glipizide Er | Glipizide | 47 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 47 | suppressed |
| Lovastatin | Lovastatin | 46 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 45 | 44 |
| Ozempic | Semaglutide | 45 | suppressed |
| Amantadine | Amantadine Hcl | 44 | suppressed |
| Amoxicillin | Amoxicillin | 44 | 30 |
| Azithromycin | Azithromycin | 44 | 28 |
| Vascepa | Icosapent Ethyl | 44 | suppressed |
| Aripiprazole | Aripiprazole | 43 | 16 |
| Calcium Acetate | Calcium Acetate | 43 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 43 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 42 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 42 | 28 |
| Pentoxifylline | Pentoxifylline | 41 | suppressed |
| Fentanyl | Fentanyl | 39 | 14 |
| Invega Sustenna | Paliperidone Palmitate | 39 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 39 | 26 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 38 | suppressed |
| Methocarbamol | Methocarbamol | 38 | 15 |
| Nitroglycerin | Nitroglycerin | 38 | 28 |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | suppressed |
| Lubiprostone | Lubiprostone | 37 | suppressed |
| Meropenem | Meropenem | 37 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 36 | 17 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 36 | 11 |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 36 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | 12 |
| Haloperidol | Haloperidol | 35 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 35 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 34 | 21 |
| Naproxen | Naproxen | 34 | 11 |
| Procrit | Epoetin Alfa | 34 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 33 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 33 | suppressed |
| Brilinta | Ticagrelor | 32 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | 13 |
| Calcitriol | Calcitriol | 32 | suppressed |
| Humalog | Insulin Lispro | 32 | 19 |
| Arnuity Ellipta | Fluticasone Furoate | 31 | suppressed |
| Creon | Lipase/Protease/Amylase | 31 | suppressed |
| Ibuprofen | Ibuprofen | 31 | 24 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 30 | suppressed |
| Ketoconazole | Ketoconazole | 30 | 15 |
| Ranolazine Er | Ranolazine | 30 | suppressed |
| Scopolamine | Scopolamine | 30 | 11 |
| Valsartan | Valsartan | 30 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 30 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 29 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 29 | suppressed |
| Carbamazepine Er | Carbamazepine | 28 | suppressed |
| Linzess | Linaclotide | 28 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | 12 |
| Methimazole | Methimazole | 28 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 28 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 28 | 19 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 27 | suppressed |
| Estradiol | Estradiol | 27 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 27 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 27 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 26 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 26 | suppressed |
| Letrozole | Letrozole | 26 | suppressed |
| Metronidazole | Metronidazole | 26 | 17 |
| Mupirocin | Mupirocin | 26 | 15 |
| Raloxifene Hcl | Raloxifene Hcl | 26 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 26 | suppressed |
| Sotalol | Sotalol Hcl | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 25 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 25 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 24 | 19 |
| Dorzolamide Hcl | Dorzolamide Hcl | 24 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | 15 |
| Levofloxacin | Levofloxacin | 23 | 14 |
| Nystop | Nystatin | 23 | 19 |
| Primidone | Primidone | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Lacosamide | Lacosamide | 22 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 22 | suppressed |
| Demeclocycline Hcl | Demeclocycline Hcl | 21 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 21 | suppressed |
| Entacapone | Entacapone | 21 | suppressed |
| Erythromycin | Erythromycin Base | 21 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 21 | suppressed |
| Rexulti | Brexpiprazole | 21 | suppressed |
| Acetazolamide | Acetazolamide | 20 | suppressed |
| Cholestyramine Light | Cholestyramine | 20 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 20 | 12 |
| Haloperidol Lactate | Haloperidol Lactate | 20 | 15 |
| Rebif | Interferon Beta-1a/Albumin | 20 | suppressed |
| Timolol Maleate | Timolol Maleate | 20 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 20 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 19 | suppressed |
| Xifaxan | Rifaximin | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 18 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 17 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 17 | 16 |
| Invokana | Canagliflozin | 17 | suppressed |
| Novolog | Insulin Aspart | 17 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Admelog Solostar | Insulin Lispro | 16 | suppressed |
| Alprazolam | Alprazolam | 16 | suppressed |
| Azathioprine | Azathioprine | 16 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 15 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | 12 |
| Insulin Aspart | Insulin Aspart | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Risperidone Er | Risperidone Microspheres | 15 | suppressed |
| Tacrolimus | Tacrolimus | 15 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 15 | suppressed |
| Valproic Acid | Valproic Acid | 15 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 14 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 14 | suppressed |
| Glimepiride | Glimepiride | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Moxifloxacin Hcl | Moxifloxacin Hcl | 14 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 13 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 13 | suppressed |
| Restasis | Cyclosporine | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Leucovorin Calcium | Leucovorin Calcium | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Vraylar | Cariprazine Hcl | 12 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Felbamate | Felbamate | 11 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Matzim La | Diltiazem Hcl | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Prolastin C | Alpha-1-Proteinase Inhibitor | 11 | suppressed |
| Ramelteon | Ramelteon | 11 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $574.96 · 12 records | AstraZeneca Pharmaceuticals LP | ADSTILADRIN, AREXVY, BREZTRI, FASENRA, NUCALA, TEZSPIRE, TRELEGY ELLIPTA | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error